LLM, Universities of Leyden Law School and Utrecht Department of Health Administration, School of Medicine
PhD, University of Amsterdam School of Medicine and Department of Science Policy
Investigator Award in Health Policy Research
Robert Wood Johnson Foundation, Princeton, NJ
The Querido-Award for the most promising young investigator in public health, the National Foundation for Health Promotion and Disease Prevention (Praeventiefonds)
The Hague, the Netherlands
International Fellow, Council on Health Care Technology
Institute of Medicine, National Academy of Sciences, Washington, DC
Neuroprotection in Patients Undergoing Aortic Valve Replacement
All patients undergoing cardiac surgery, including AVR, face a risk for injury to the brain including stroke. Debris, such as plaque, may be dislodged from the wall of the aorta (the blood vessel leading from the heart to the brain and the rest of the body) during surgery. &...
LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function
The main purpose of this research is to determine whether injecting mesenchymal precursor cells (MPC) into the heart during surgery to implant a left ventricular assist device (LVAD) is safe and effective in improving heart function. MPCs are normally present in human bone ...
Management Practices and the Risk of Infection Following Cardiac Surgery
The purpose of the study is to determine the best ways to prevent infections after heart surgery. Participation in the study will last at most 3 months after heart surgery. The study will only collect information about the care patients receive during their planned surgery, and n...
Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
The main purpose of this research is to determine whether injecting mesenchymal precursor cells (MPC) into the heart during surgery to implant a left ventricular assist device (LVAD) is safe. In addition, this research is being done to test whether injecting the MPCs into t...
Surgical Ablation vs No Surgical Ablation for Patients with Persistent or Longstanding Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery
The purpose of the research is to determine whether treating atrial fibrillation with surgical ablation during scheduled mitral valve surgery is better than mitral valve surgery by itself without the surgical ablation. Surgical ablation of atrial fibrillation is a technique used ...
The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,
The purpose of this prospective cohort study is to characterize the specific sites and timing of clotting cascade activation triggered by CPB (cardiopulmonary bypass) and VAD (Ventricular Assist Device) therapy in end-stage heart failure patients. To control for the effect of hea...
Rate Control versus Rhythm Control for Postoperative Atrial Fibrillation
The purpose of the research is to compare two strategies for treating atrial fibrillation or atrial flutter, both of which are referred to as AF, after cardiac surgery. AF is the most common complication after cardiac surgery. AF is when the upper chambers of the heart (atr...
Cardiothoracic Surgical Trials Network
The goal of the Cardiothoracic Surgical Trials Network (CTSN) is to foster a culture of rigorous scientific comparisons and to promote the evaluation of newer surgical techniques, devices, and innovative pharmaceutical and bioengineered products directed at improving cardiovascul...
Gelijns A, Gabriel S. Looking beyond Translation — Integrating Clinical Research with Medical Practice. New England Journal of Medicine 2012 May 3; 366(18): 1659-66.
Gardner T, Miller M, O'Gara P, Gelijns A. Building an infrastructure for clinical trials in cardiac surgery. J Thorac Cardiovasc Surg 2011 Aug; 142(2): 265-6.
Gillinov A, Argenziano M, Blackstone E, Iribarne A, DeRose J, Ailawadi G, Russo M, Ascheim D, Parides M, Rodriguez E, Bouchard D, Taddei-Peters W, Geller N, Acker M, Gelijns A. Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg 2011 Aug; 142(2): 257-64.
Greco G, Egorova N, Gelijns A, Moskowitz A, Manganaro A, Zwolak R, Riles T, Kent K. Development of a novel scoring tool for the identification of large ≥5 cm abdominal aortic aneurysms. Ann Surg 2012 Oct; 252(4): 675-82.
Egorova N, Gelijns A, Moskowitz A, Emond J, Krapf R, Lazar E, Guillerme S, Kaplan H, Greco G. Process of care events in transplantation: effects on the cost of hospitalization. Am J Transplant 2010 Oct; 10(10): 2341-8.
Gelijns A, Ascheim D, Parides M, Kent K, Moskowitz A. Randomized trials in surgery. Surgery 2009 Jun; 145(6): 581-7.
Ascheim D, Gelijns A, Rose E. Innovation with experience using implantable left ventricular assist devices. Circ Heart Fail 2009 Jan; 2(1): 1-2.
Iribarne A, Russo M, Moskowitz A, Ascheim D, Brown L, Gelijns A. Assessing technological change in cardiothoracic surgery. Semin Thorac Cardiovasc Surg 2009 Spring; 21(1): 28-34.
Russo M, Gelijns A, Stevenson L, Sampat B, Aaronson K, Renlund D, Ascheim D, Hong K, Oz M, Moskowitz A, Rose E, Miller L. The Cost of Medical Management in Advanced Heart Failure during the Final Two Years of Life. Rematch Investigators. J Heart Failure 2008 Oct; 14 (8): 651-658.
Egorova N, Moskowitz A, Gelijns A, Weinberg A, Curty J, Rabin-Fastman B, Kaplan H, Cooper M, Fowler D, Emond J, Greco G. Managing the prevention of retained surgical instruments: what is the value of counting? . Annals of Surgery 2008; 247: 13-18.
Neaton J, Normand S, Gelijns A, Starling R, Mann D, Konstam M. Designs for mechanical circulatory support device studies. Journal of Cardiac Failure 2007 Feb; 13(1): 63-74.
Parides M, Moskowitz A, Ascheim D, Rose E, Gelijns A. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Annals of Thoracic Surgery 2006 Sep; 82(3): 1140-6.
Gelijns A, Thier S. Medical Innovation and Institutional Interdependence; Rethinking University-Industry Connections. . JAMA 2002 January; 287: 72-77.
Rose E, Gelijns A, Moskowitz A. Long Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure. The New England Journal of Medicine 2001; 345: 1435-1443.
Gelijns A, Rosenberg N, Moskowitz A. Capturing the Unexpected Benefits of Medical Research. New Engl J Med 1998; 339: 693-8.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Gelijns during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.